These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32892791)

  • 1. Effects of maternal depression and prenatal SSRI exposure on executive functions and susceptibility to household chaos in 6-year-old children: prospective cohort study.
    Dhaliwal G; Weikum WM; Jolicoeur-Martineau A; Brain U; Grunau RE; Oberlander TF
    BJPsych Open; 2020 Sep; 6(5):e106. PubMed ID: 32892791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
    Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
    Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age.
    Weikum WM; Brain U; Chau CM; Grunau RE; Boyce WT; Diamond A; Oberlander TF
    Front Cell Neurosci; 2013; 7():180. PubMed ID: 24130516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.
    Oberlander TF; Reebye P; Misri S; Papsdorf M; Kim J; Grunau RE
    Arch Pediatr Adolesc Med; 2007 Jan; 161(1):22-9. PubMed ID: 17199063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study.
    Hutchison SM; Brain U; Grunau RE; Kuzeljevic B; Irvine M; Mâsse LC; Oberlander TF
    BJPsych Open; 2023 Feb; 9(2):e26. PubMed ID: 36721917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Prenatal Selective Serotonin Reuptake Inhibitor Antidepressant Exposure and Maternal Mood on Physical Activity, Dietary Intake, and Markers of Adiposity at Age 6 Years.
    Hutchison SM; Mâsse LC; Glier MB; Brain U; Devlin AM; Oberlander TF
    J Dev Behav Pediatr; 2019 May; 40(4):266-274. PubMed ID: 30950906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 6-year longitudinal study: Are maternal depressive symptoms and Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant treatment during pregnancy associated with everyday measures of executive function in young children?
    Hutchison SM; Mâsse LC; Brain U; Oberlander TF
    Early Hum Dev; 2019 Jan; 128():21-26. PubMed ID: 30447406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
    Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
    Rotem-Kohavi N; Oberlander TF
    Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy.
    Inkster AM; Konwar C; Peñaherrera MS; Brain U; Khan A; Price EM; Schuetz JM; Portales-Casamar É; Burt A; Marsit CJ; Vaillancourt C; Oberlander TF; Robinson WP
    Sci Rep; 2022 Dec; 12(1):22576. PubMed ID: 36585414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
    Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H
    JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
    van der Veere CN; de Vries NKS; van Braeckel KNJA; Bos AF
    Early Hum Dev; 2020 Aug; 147():105075. PubMed ID: 32504880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure.
    Oberlander TF; Grunau R; Mayes L; Riggs W; Rurak D; Papsdorf M; Misri S; Weinberg J
    Early Hum Dev; 2008 Oct; 84(10):689-97. PubMed ID: 18639992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age.
    Weikum WM; Mayes LC; Grunau RE; Brain U; Oberlander TF
    Infant Behav Dev; 2013 Dec; 36(4):485-93. PubMed ID: 23728194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children.
    Lupattelli A; Wood M; Ystrom E; Skurtveit S; Handal M; Nordeng H
    J Am Acad Child Adolesc Psychiatry; 2018 Mar; 57(3):200-208. PubMed ID: 29496129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.